EDSA Stock Price History and Quote Analysis: Insights for Investors
Edesa Biotech, Inc.
Stock Price Today
Edesa Biotech, Inc. (EDSA) stock surged +1.86%, trading at $4.37 on NASDAQ, up from the previous close of $4.29. The stock opened at $4.43, fluctuating between $4.36 and $4.55 in the recent session.
Stock Snapshot
Stock Price History Chart
Contact Details
About Company
Edesa Biotech, Inc., a biopharmaceutical company, engages in acquiring, developing, and commercializing clinical-stage drugs for inflammatory and immune-related diseases with clear unmet medical needs. Its lead product candidates are EB05, a monoclonal antibody, which is in Phase 3 clinical study for the treatment of acute respiratory distress syndrome in covid-19 patients; and EB01, a topical treatment that is in Phase 2B clinical study for chronic allergic contact dermatitis. It has a license agreement with NovImmune SA to develop monoclonal antibodies targeting TLR4 and CXCL10. Edesa Biotech, Inc. was founded in 2015 and is headquartered in Markham, Canada.
Company Information
| Employees | 16 |
| Beta | 0.801 |
| Sales or Revenue | $0.00 |
| 5Y Sales Change% | -1% |
| Fiscal Year Ends | September |
| Sector | Healthcare |
| Industry | Biotechnology |
Frequently Asked Questions
Edesa Biotech, Inc. (NASDAQ: EDSA) stock price is $4.37 in the last trading session. During the trading session, EDSA stock reached the peak price of $4.55 while $4.36 was the lowest point it dropped to. The percentage change in EDSA stock occurred in the recent session was 1.86% while the dollar amount for the price change in EDSA stock was $0.08.
The NASDAQ listed EDSA is part of Biotechnology industry that operates in the broader Healthcare sector. Edesa Biotech, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.
Dr. Michael J. Brooks M.B.A., Ph.D.
Pres
Mr. Rajan Puri
Senior Vice President of Manufacturing
Ms. Kathi Niffenegger CPA, CPA
Chief Financial Officer
Mr. Gary Koppenjan
Vice President of Investor Relations & Communications
Ms. Kathi Niffenegger C.P.A., CPA
Chief Financial Officer
Mr. Stephen L. Lemieux BA, CA, CPA, MMPA
Chief Financial Officer
Dr. Pardeep Nijhawan FRCPC, M.D.
Chief Executive Officer, Company Sec. & Director
EDSA's closing price is 77.64% higher than its 52-week low of $2.46 where as its distance from 52-week high of $8.33 is -47.54%.
Number of EDSA employees currently stands at 16.
Official Website of EDSA is: https://www.edesabiotech.com
EDSA could be contacted at phone 289 800 9600 and can also be accessed through its website. EDSA operates from 100 Spy Court, Markham, ON L3R 5H6, Canada.
EDSA stock volume for the day was 3.89K shares. The average number of EDSA shares traded daily for last 3 months was 8.47K.
The market value of EDSA currently stands at $14.19M with its latest stock price at $4.37 and 3.25M of its shares outstanding.
Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.
© 2024 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com